GoKawiil
Tech News
A Nature Index 2026 feature on regenerative medicine reviews progress in cell therapy and tissue engineering, including the use of induced pluripotent stem cells (iPSCs) to pursue treatments for autoimmune diseases, Parkinson's disease and heart failure. It also notes clinical trials using stem-cell transplants to replace insulin-producing cells in people with type 1 diabetes have shown some success.
Researchers report that a young boy's cancer went into remission after receiving an experimental form of CAR T cell therapy. The treatment is part of ongoing efforts to adapt CAR T technology, previously effective mainly against blood cancers, to target solid tumors.
Researchers gave ten older women with severe osteoporosis a single infusion of their own bone-marrow cells, which had been lab-modified to better home in on bone tissue. Before the treatment the women fractured bones roughly every one to two years; afterward, low-impact fractures dropped to about once per decade, according to a study published in Cell.
Novartis suspended eight clinical trials testing a cell therapy for autoimmune and neurological conditions after three participants died in late August. The company has not disclosed the cause of death or which specific therapy is affected beyond confirming the pause across all related studies.